Desmin dysregulation in gall bladder cancer.
作者信息
Mittal Balraj
机构信息
Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow 226 025, Uttar Pradesh, India.
出版信息
Indian J Med Res. 2020 Apr;151(4):273-274. doi: 10.4103/ijmr.IJMR_1540_19.
Abstract
摘要
相似文献
1
Desmin dysregulation in gall bladder cancer.
Indian J Med Res. 2020 Apr;151(4):273-274. doi: 10.4103/ijmr.IJMR_1540_19.
2
Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression.
Indian J Med Res. 2020 Apr;151(4):311-318. doi: 10.4103/ijmr.IJMR_501_18.
3
Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
Gene. 2016 Feb 1;576(2 Pt 2):743-52. doi: 10.1016/j.gene.2015.10.004. Epub 2015 Oct 8.
4
Adult rhabdomyosarcoma of the gall bladder: case report and review of published works.
Gut. 1994 Jun;35(6):854-6. doi: 10.1136/gut.35.6.854.
5
An uncommon case of gall bladder mass: gall bladder tuberculosis.
Trop Doct. 2019 Apr;49(2):136-138. doi: 10.1177/0049475519829601. Epub 2019 Feb 19.
6
Colour Doppler-guided spectral analysis of gall-bladder wall flow.
J Gastroenterol Hepatol. 1998 Feb;13(2):181-5. doi: 10.1111/j.1440-1746.1998.tb00635.x.
7
Randomized-Control Screening Trials to Lower Gall Bladder Cancer Mortality in High Risk Populations.
Asian Pac J Cancer Prev. 2016;17(4):2325-7. doi: 10.7314/apjcp.2016.17.4.2325.
8
Malignancy of the gall bladder associated with chronic cholelithiasis.
Minn Med. 1948 Mar;31(3):274.
9
Laparoscopic cholecystectomy in the treatment of gallbladder polypoid lesions--15 years of experience.
Pol Przegl Chir. 2013 Nov;85(11):625-9. doi: 10.2478/pjs-2013-0094.
10
Elucidation of the Chemopreventive Role of Stigmasterol Against Jab1 in Gall Bladder Carcinoma.
Endocr Metab Immune Disord Drug Targets. 2019;19(6):826-837. doi: 10.2174/1871530319666190206124120.
引用本文的文献
1
In vivo antiangiogenic effect of nimbolide, trans-chalcone and piperine for use against glioblastoma.
BMC Cancer. 2023 Nov 30;23(1):1173. doi: 10.1186/s12885-023-11625-4.
2
Identification of immunocell infiltrates and effective diagnostic biomarkers in laryngeal carcinoma.
Medicine (Baltimore). 2023 Jan 20;102(3):e32548. doi: 10.1097/MD.0000000000032548.
3
Cancer and Associated Therapies Impact the Skeletal Muscle Proteome.
Front Physiol. 2022 May 27;13:879263. doi: 10.3389/fphys.2022.879263. eCollection 2022.
4
Prognostic Nomograms to Predict Survival of Patients with Resectable Gallbladder Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Analysis.
Med Sci Monit. 2021 Mar 30;27:e929106. doi: 10.12659/MSM.929106.
本文引用的文献
1
Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression.
Indian J Med Res. 2020 Apr;151(4):311-318. doi: 10.4103/ijmr.IJMR_501_18.
2
Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease.
Tumour Biol. 2016 Nov;37(11):14687-14699. doi: 10.1007/s13277-016-5355-9. Epub 2016 Sep 14.
3
Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels.
Clin Proteomics. 2011 Dec 5;8(1):16. doi: 10.1186/1559-0275-8-16.
4
Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
Mol Cell Proteomics. 2009 Aug;8(8):1878-90. doi: 10.1074/mcp.M800541-MCP200. Epub 2009 May 20.
5
Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle.
Exp Cell Res. 2004 Nov 15;301(1):1-7. doi: 10.1016/j.yexcr.2004.08.004.
6
The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation?
J Struct Biol. 2004 Nov;148(2):137-52. doi: 10.1016/j.jsb.2004.04.003.
7
Intermediate filament proteins during carcinogenesis and apoptosis (Review).
Int J Oncol. 1999 Mar;14(3):563-70. doi: 10.3892/ijo.14.3.563.
Zotero 插件